ITGAM and central nervous system cancer: Furthermore, utilizing a CD11b-HSVTK transgenic mouse model of glioma implantation, we demonstrated that the elimination of microglia/macrophages in implanted tumors resulted in a significant downregulation of pPyk2(579/580) in glioma cells [24].